Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Anemia

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 17 articles: HTML format

Single Articles

April 2025
1. SMITH-JACKSON K, Walsh P, Zelek WM, Hoyler T, et al
   The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndrome.
   Kidney Int. 2025;107:700-713.
   PubMed     Abstract available
   
   
   December 2024
2. KAVANAGH D, Ardissino G, Brocklebank V, Bouwmeester RN, et al
   Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.
   Kidney Int. 2024;106:1038-1050.
   PubMed     Abstract available
   
   
   September 2024
3. NESTER CM, Feldman DL, Burwick R, Cataland S, et al
   An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group.
   Kidney Int. 2024;106:326-336.
   PubMed     Abstract available
   
   
   
4. VIVARELLI M, Barratt J, Beck LH Jr, Fakhouri F, et al
   The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
   Kidney Int. 2024;106:369-391.
   PubMed     Abstract available
   
   
   August 2024
5. WILLICOMBE M, Roberts DJ
   TRANSFUSION-INDUCED HLA SENSITISATION IN WAITLIST PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS.
   Kidney Int. 2024 Aug 22:S0085-2538(24)00573-8. doi: 10.1016/j.kint.2024.
   PubMed     Abstract available
   
   
   May 2024
6. MAISONS V, Duval A, Mesnard L, Frimat M, et al
   Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
   Kidney Int. 2024;105:1100-1112.
   PubMed     Abstract available
   
   
   
7. CHE M, Moran SM, Smith RJ, Ren KYM, et al
   A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
   Kidney Int. 2024;105:960-970.
   PubMed     Abstract available
   
   
   April 2024
8. CORNELL LD, Shankaranarayanan D, Rodriguez PS, Damgard SE, et al
   Sickle cell disease in the kidney transplant.
   Kidney Int. 2024;105:892.
   PubMed    
   
   
   February 2024
9. ZHANG Y, Martin B, Spies MA, Roberts SM, et al
   Renin and renin blockade have no role in complement activity.
   Kidney Int. 2024;105:328-337.
   PubMed     Abstract available
   
   
   January 2024
10. KAARTINEN K, Schenk P, Raisanen-Sokolowski A, Dunkel J, et al
    The Case | Refractory anemia in a patient undergoing dialysis.
    Kidney Int. 2024;105:211-212.
    PubMed    
    
    
    October 2023
11. HUERTA A, Arjona E, Portoles J, Lopez-Sanchez P, et al
    On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
    Kidney Int. 2023;104:851-855.
    PubMed    
    
    
    September 2023
12. ECKARDT KU, Kurtz A
    Secrets and myths between tubules - new insights on erythropoietin production from single cell technology.
    Kidney Int. 2023 Sep 13:S0085-2538(23)00634-8. doi: 10.1016/j.kint.2023.
    PubMed    
    
    
    August 2023
13. LABOUX T, Maanaoui M, Allain F, Boulanger E, et al
    Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
    Kidney Int. 2023;104:353-366.
    PubMed     Abstract available
    
    
    July 2023
14. KOURY MJ, Haase VH
    Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD.
    Kidney Int. 2023;104:25-28.
    PubMed     Abstract available
    
    
    June 2023
15. LOCATELLI F, Del Vecchio L
    Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD.
    Kidney Int. 2023;103:1025-1027.
    PubMed     Abstract available
    
    
    May 2023
16. KU E, Del Vecchio L, Eckardt KU, Haase VH, et al
    Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 May 24:S0085-2538(23)00379-4. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    March 2023
17. OLIVARI V, Di Modica SM, Lidonnici MR, Aghajan M, et al
    A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00179-5. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.